A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis

International Journal of Immunogenetics

Volumn 33, Issue 3, 2006, Pages 155-161

  Abdallah, A M ^a   Renzoni, E A ^a   Anevlavis, S ^a   Lagan, A L ^a   Munkonge, F M ^a   Fonseca, C ^b   Black, C M ^b   Briggs, D ^c   Wells, A U ^a   Marshall, S E ^a   McHugh, N ^d   Du Bois, R M ^a   Welsh, K I ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; NUCLEAR PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSCRIPTION FACTOR GATA 1;

ALGORITHM; ALLELE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GEL MOBILITY SHIFT ASSAY; HAPLOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; UNITED KINGDOM;

ALGORITHMS; ALLELES; ANTIGENS, CD86; BINDING SITES; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RESPONSE ELEMENTS; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SOFTWARE;

EID: 33646867177     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2006.00580.x     Document Type: Article

References (39)

1. Arnett, F.C., Cho, M., Chatterjee, S., Aguilar, M.B., Reveille, J.D. Mayes, M.D. 2001 Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis and Rheumatism, 44, 1359.
2. Atamas, S.P., Yurovsky, V.V., Wise, R., Wigley, F.M., Goter Robinson, C.J., Henry, P., Alms, W.J. White, B. 1999 Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis and Rheumatism, 42, 1168.
3. Bunce, M., Fanning, G.C. Welsh, K.I. 1995 Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens, 45, 81.
4. Eagar, T.N., Turley, D.M., Padilla, J., Karandikar, N.J., Tan, L., Bluestone, J.A. Miller, S.D. 2004 CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance. Journal of Immunology, 172, 7442.
5. Englert, H., Small-McMahon, J., Chambers, P., O'Connor, H., Davis, K., Manolios, N., White, R., Dracos, G. Brooks, P. 1999 Familial risk estimation in systemic sclerosis. Australian and New Zealand Journal of Medicine, 29, 36.
6. Fertin, C., Nicolas, J.F., Gillery, P., Kalis, B., Banchereau, J. Maquart, F.X. 1991 Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Cell Molecular Biology, 37, 823.
7. Freeman, G.J., Boussiotis, V.A., Anumanthan, A., Bernstein, G.M., Ke, X.Y., Rennert, P.D., Gray, G.S., Gribben, J.G. Nadler, L.M. 1995 B7 and B7 do not deliver identical costimulatory signals, since B7 but not B7 preferentially costimulates the initial production of IL-4. Immunity, 2, 523.
8. Freundlich, B. Jimenez, S.A. 1987 Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of d-penicillamine therapy. Clinical Experimental Immunology, 69, 375.
9. Fried, M.G. 1989 Measurement of protein-DNA interaction parameters by electrophoresis mobility shift assay. Electrophoresis, 10, 366.
10. Fujitsu, Y., Fukuda, K., Kumagai, N. Nishida, T. 2003 IL-4-induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts. Experimental Eye Research, 76, 107.
11. Greenfield, E.A., Nguyen, K.A. Kuchroo, V.K. 1998 CD28/B7 costimulation: a review. Critical Reviews in Immunology, 18, 389.
12. Gribben, J.G et al. 1995 CTLA4 mediates antigen-specific apoptosis of human T cells. Proceedings of the National Academy of Sciences of the USA, 92, 811.
13. Hamilton, R.F. Jr., Parsley, E. Holian, A. 2004 Alveolar macrophages from systemic sclerosis patients: evidence for IL-4-mediated phenotype changes. American Journal of Physiological Lung Cell Molecular Physiology, 286, L1202 L1209.
14. Kantor, T.V., Friberg, D., Medsger, T.A. Jr., Buckingham, R.B. Whiteside, T.L. 1992 Cytokine production and serum levels in systemic sclerosis. Clinical Immunological Immunopathology, 65, 278.
15. Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N. Glimcher, L.H. 1995 B7 and B7 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell, 80, 707.
16. Kuwana, M., Medsger, T.A. Jr. Wright, T.M. 1995 T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis. Journal of Immunology, 155, 2703.
17. Lazarus, R et al. 2002 Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunological Review, 190, 9.
18. Legerton, C.W. III., Smith, E.A. Silver, R.M. 1995 Systemic sclerosis (scleroderma). Clinical management of its major complications. Rheumatic Diseases Clinics of North America, 21, 203.
19. LeRoy, E.C., Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger, T.A. Jr., Rowell, N. Wollheim, F. 1988 Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. Journal of Rheumatology, 15, 202.
20. Lewis, S.E. Konradi, C. 1996 Analysis of DNA-Protein Interactions in the Nervous System Using the Electrophoretic Mobility Shift Assay. Methods, 10, 301.
21. Matsushita, M., Tsuchiya, N., Oka, T., Yamane, A. Tokunaga, K. 2000 New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus. Genes Immunity, 1, 428.
22. Mattey, D.L., Dawes, P.T., Nixon, N.B. Slater, H. 1997 Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Annals of the Rheumatic Diseases, 56, 426.
23. Mavalia, C., Scaletti, C., Romagnani, P., Carossino, A.M., Pignone, A., Emmi, L., Pupilli, C., Pizzolo, G., Maggi, E. Romagnani, S. 1997 Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. American Journal of Pathology, 151, 1751.
24. Moser, M. 2001 Regulation of Th1/Th2 development by antigen-presenting cells in vivo. Immunobiology, 204, 551.
25. Needleman, B.W., Wigley, F.M. Stair, R.W. 1992 Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis and Rheumatism, 35, 67.
26. Oliver, S.J. 2000 The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide. Current Rheumatology Report, 2, 486.
27. Prior, C. Haslam, P.L. 1992 In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. Clinical Experimental Immunology, 88, 280.
28. van Rijt, L.S., Vos, N., Willart, M., Kleinjan, A., Coyle, A.J., Hoogsteden, H.C. Lambrecht, B.N. 2004 Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma. Journal of Allergy and Clinical Immunology, 114, 166.
29. Sakkas, L.I., Xu, B., Artlett, C.M., Lu, S., Jimenez, S.A. Platsoucas, C.D. 2002 Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. Journal of Immunology, 168, 3649.
30. Sansom, D.M., Manzotti, C.N. Zheng, Y. 2003 What's the difference between CD80 and CD86? Trends in Immunology, 24, 314.
31. Sato, H et al. 2004 The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma. Arthritis and Rheumatism, 50, 558.
32. Sato, H., Grutters, J.C., Pantelidis, P., Mizzon, A.N., Ahmad, T., Van Houte, A.J., Lammers, J.W., van den Bosch, J.M., Welsh, K.I. du Bois, R.M. 2002 HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. American Journal of Respiratory Cell and Molecular Biology, 27, 406.
33. Sempowski, G.D., Derdak, S. Phipps, R.P. 1996 Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. Journal of Cell Physiology, 167, 290.
34. Sgonc, R. 1999 The vascular perspective of systemic sclerosis: of chickens, mice and men. International Archives of Allergy Immunology, 120, 169.
35. Sharpe, A.H. Freeman, G.J. 2002 The B7-CD28 superfamily. Nature Reviews. Immunology, 2, 116.
36. Skapenko, A., Leipe, J., Niesner, U., Devriendt, K., Beetz, R., Radbruch, A., Kalden, J.R., Lipsky, P.E. Schulze-Koops, H. 2004 GATA-3 in human T cell helper type 2 development. Journal of Experimental Medicine, 199, 423.
37. Teutsch, S.M., Booth, D.R., Bennetts, B.H., Heard, R.N. Stewart, G.J. 2004 Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients. Journal of Neuroimmunology, 148, 218.
38. Wang, Z., Takamoto, M. Sugane, K. 2000 Costimulatory signal through CD86 is important in Th2 response in Trichinella spiralis infected mice. Parasite Immunology, 22, 121.
39. Wells, A.U., Lorimer, S., Majumdar, S., Harrison, N.K., Corrin, B., Black, C.M., Jeffery, P.K. du Bois, R.M. 1995 Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. European Respiratory Journal, 8, 266.